MedTrace Logo

CARD for Community Pharmacy Vaccinations - Phase 2

NCT06666868 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2024-10-31

No results posted yet for this study

Summary

This study is phase 2 of a cluster trial integrating the CARD (Comfort Ask Relax System) in community pharmacies affiliated with Wholehealth Pharmacy Partners. It involves continuing CARD in pharmacies randomized to CARD in phase 1 of the trial (2023-2024 fall/winter vaccination season), and initiating CARD in pharmacies randomized to Control (usual care) in phase 1 of the trial. Both groups will use CARD for delivery of vaccinations during the 2024-2025 fall/winter vaccination season.

Conditions

  • Vaccination
  • Vaccination Pain
  • Vaccination Reaction
  • Vaccination Pharmacy

Interventions

BEHAVIORAL

Sustained CARD

This group is using CARD for the 2nd year in a row in participating pharmacies as the vaccination delivery framework (It was used in the 2023-2024 fall/winter vaccination season and is now being sustained in the 2024-2025 fall/winter vaccination season).

BEHAVIORAL

First-time CARD

CARD is being used for the 1st time in participating pharmacies as the vaccination delivery framework (2024-2025 fall/winter vaccination season).

Sponsors & Collaborators

  • Wholehealth Pharmacy Partners

    collaborator UNKNOWN

  • University of Toronto

    lead OTHER

Principal Investigators

  • Anna Taddio, PhD · Leslie Dan Faculty Of Pharmacy, University Of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-05
Primary Completion
2025-03-31
Completion
2025-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06666868 on ClinicalTrials.gov